Lipid peroxidation and immune activation: TRAF3's double-edged strategy against glioblastoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40166928.
- Also identified by DOI 10.1172/JCI190471 and PMC identifier 11957689.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Glioblastoma (GBM), the most aggressive type of primary brain tumor, continues to defy therapeutic advances with its metabolic adaptability and resistance to treatment. In this issue of the JCI, Zeng et al. delve into a pivotal mechanism underpinning this adaptability. They identified an important role for TNF receptor-associated factor 3 (TRAF3) in regulating lipid metabolism through its interaction with enoyl-CoA hydratase 1 (ECH1). These findings elucidate a unique signaling axis that shields GBM cells from lipid peroxidation and antitumor immunity, advancing therapeutic strategies for GBM that may also carry over to other cancers with similar metabolic vulnerabilities.
Medical subject headings
- Glioblastoma
- Lipid Peroxidation
- Brain Neoplasms
- TNF Receptor-Associated Factor 3
- Neoplasm Proteins